21 November 2023
\n \n \n \nTo mark World Antimicrobial Awareness Week, researchers supported by the Oxford Martin Programme on Antimicrobial Resistance Testing at the University of Oxford have reported advances towards a novel and rapid antimicrobial susceptibility test that can return results within as little as 30 minutes - significantly faster than current gold-standard approaches.
\n \n\n \n \n15 November 2023
\n \n \n \nAhead of World AMR Awareness Week (18 - 24 November), researchers from the Ineos Oxford Institute for antimicrobial research (IOI) came together to bring to life the dangers of AMR, one of the biggest public health threats facing the world today.
\n \n\n \n \n6 October 2023
\n \n \n \nA new study led by the University of Oxford has found that natural evolution of antibiotic resistance genes has maintained resistance in bacteria despite a reduction in the use of antibiotics. The findings demonstrate the importance of understanding the regulatory evolution of resistance genes to strategically combat AMR. The study has been published in the Journal of the International Society for Microbial Ecology (ISME).
\n \n\n \n \n4 October 2023
\n \n \n \nProfessor Harrison Steel\u2019s group in the Department of Engineering Science, the only international member of a cross-disciplinary team led by Harvard Medical School, will scale up existing technologies and translate them to clinical use to support the global fight against antimicrobial resistance
\n \n\n \n \n12 July 2023
\n \n \n \nA research study led by researchers in the Department of Biology provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections which could help develop more effective interventions to prevent AMR infections developing in vulnerable patients.
\n \n\n \n \n25 April 2023
\n \n \n \nResearch led by Dr Craig MacLean, Department of Biology, has shown that overuse of antimicrobials in livestock production can drive the evolution of bacteria more resistant to the first line of the human immune response, and that farmed pigs and chickens could harbour large reservoirs of cross-resistant bacteria.
\n \n\n \n \n15 March 2023
\n \n \n \nThe antibiotic colistin is being widely used to prevent infections and promote growth in animals grown for human consumption such as poultry.
\n \n\n \n \n3 March 2023
\n \n \n \nThe Prime Minister of Bangladesh, Sheikh Hasina, met Professor Timothy Walsh, Research Director (Biology) at the Ineos Oxford Institute for Antimicrobial Research, to discuss her continued commitment to tackling the issue of antimicrobial resistance (AMR) in Bangladesh and around the world.
\n \n\n \n \n25 November 2022
\n \n \n \nAs part of World Antimicrobial Awareness Week, the Ineos Oxford Institute for Antimicrobial Research and Oxford Martin School hosted a symposium on 'The Rising Tide of Antimicrobial Resistance: A high price to pay', bringing together experts from research, industry, policy and finance to discuss the threat and opportunities to address it.
\n \n\n \n \n22 November 2022
\n \n \n \nA new study, led by researchers from the Department of Biology and released during World Antimicrobial Awareness Week, has significant findings on how antimicrobial resistance (AMR) arises and persists.
\n \n\n \n \n3 November 2022
\n \n \n \nA new study, involving researchers in the departments of Chemistry and Biochemistry and the Kavli Institute, sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
\n \n\n \n \n8 August 2022
\n \n \n \nResearchers at the Ineos Oxford Institute for Antimicrobial Resistance (IOI) and the Department of Biology have revealed links between the presence of bacteria that is resistant to antibiotics in mothers and their newborn babies, drawing on data from seven low- and middle-income countries in Africa and South Asia.
\n \n\n \n \n29 June 2022
\n \n \n \nProfessor Sheppard will join the Department of Biology and the IOI in September 2022, with the aim of using fundamental evolutionary and ecological theory to address consequential questions in pathogen emergence and spread.
\n \n\n \n \n8 June 2022
\n \n \n \nA study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.
\n \n\n \n \n1 June 2022
\n \n \n \nFunding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
\n \n\n \n \n6 January 2022
\n \n \n \nScientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
\n \n\n \n \n14 December 2021
\n \n \n \nScientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
\n \n\n \n \n30 September 2021
\n \n \n \nAMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.
\n \n\n \n \n10 August 2021
\n \n \n \nInformation about the most effective antibiotics to use in low and middle income countries (LMICs) for neonatal sepsis has been discovered uniquely combining epidemiological, genomic and pharmacodynamic data.
\n \n\n \n \n9 June 2021
\n \n \n \nA cross-disciplinary team from the Universities of Oxford, Ulster and UCL have announced major funding from EPSRC to tackle the growing challenge of Antimicrobial Resistance (AMR).
\n \n\n \n \n